A molecular design approach to peptide drug stabilization

被引:1
|
作者
Thompson, S. M.
Sinha, S.
Topp, E. M.
Camarda, K. V. [1 ]
机构
[1] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA
[2] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
关键词
molecular simulation; optimization; peptide drugs; polymer;
D O I
10.1080/08927020600612213
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Many peptide drugs are susceptible to chemical degradation. It has been demonstrated experimentally that complexing a polymer to a peptide can prevent its degradation; however, the mechanism behind the stabilizing effect is not known, making it-difficult to design polymers specifically for this purpose. In this work, we have used molecular dynamics experiments to gain insight into the polymer's stabilizing effect. The system AcVYGNGA, a model peptide, which has been extensively studied experimentally, was explored both alone in various forms and complexed with poly(vinylpyrrolidone) (PVP). Results suggest that the peptide-polymer complex must have a secondary structure such that the polymer affects the critical degradation mechanism in two ways: a steric effect based on the polymer's size, and a structural effect by which the physical distance between the reacting atoms within the peptide is increased. These results will be used to develop a set of structure-property relations which can be included within an optimization framework to design new polymers for peptide stabilization.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 50 条
  • [21] Molecular design and stabilization mechanism of acrylonitrile bipolymer
    Ju, Anqi
    Guang, Shanyi
    Xu, Hongyao
    JOURNAL OF APPLIED POLYMER SCIENCE, 2013, 129 (06) : 3255 - 3264
  • [22] Molecular modeling of peptide-drug amphiphiles
    Kang, Myungshim
    Manandhar, Anjela
    Tang, Phu
    Loverde, Sharon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [23] MOLECULAR MODIFICATION IN DRUG DESIGN
    AUTERHOF.H
    ARCHIV DER PHARMAZIE UND BERICHTE DER DEUTSCHEN PHARMAZEUTISCHEN GESSELSCHAFT, 1965, 298 (02): : 143 - &
  • [24] MOLECULAR MODELING IN DRUG DESIGN
    TOPLISS, JG
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (12) : 2229 - 2229
  • [25] Molecular modeling for drug design
    Metternich, R
    CHIMIA, 2000, 54 (1-2) : 35 - 36
  • [26] MOLECULAR TOXICOLOGY AND DRUG DESIGN
    VERMEULEN, NPE
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1986, 8 (06) : 331 - 331
  • [27] Molecular Modeling in Drug Design
    Wade, Rebecca C.
    Salo-Ahen, Outi M. H.
    MOLECULES, 2019, 24 (02)
  • [28] MOLECULAR MODIFICATION IN DRUG DESIGN
    不详
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1965, 92 (05) : 250 - &
  • [29] Molecular modelling and drug design
    Laguerre, Michel
    BULLETIN DU CANCER, 2007, 94 : F115 - F127
  • [30] MOLECULAR MODIFICATION IN DRUG DESIGN
    DRAIN, D
    CHEMISTRY & INDUSTRY, 1965, (14) : 592 - &